NYBA | GenomeWeb


NEW YORK (GenomeWeb News) – The New York Economic Development Corporation said today it has launched an initiative that will inject $100 million into life sciences startup companies located in the city through a mix of money from city government, life sciences companies, and venture capital partn

Around the Regions


California Institute for Regenerative Medicine, Vermont Pharma Marketing Disclosure Bills, New England Biotech Association, US Energy Frontier Research Centers, Donald Danforth Plant Science Center, New York Biotechnology Association, Pharmaceutical Research and Manufacturers of America, Idea Networks of Biomedical Research Excellence, Pittsburgh Entrepreneur Fund, Massachusetts Life Sciences Center Accelerator Program, Maryland Technology Development Corporation, San Diego Center for Algae Biotechnology

BioRegion Newsmakers


Warren Bruggeman, Thomas Herzog, Lee Potts, Corey Goodman, Gregory Webb, Stephen Sands, Maggie Dias, Santiago Galvez, Elizabeth Goodman, Claudia Hillinger, Thad Seymour, Randy Scott, John Spencer, Thomas Stevens, Jim Talton, Daniel Wahby, Stephanie Warrington, Claudia Zylberberg

An influx of managerial and scientific talent due to layoffs from financial institutions and pharmaceutical companies, coupled with new incubator space, could help build a university-fueled life sciences cluster in the New York region, said tech-transfer experts at last week's New York Biotechnology Association meeting.

Silicon Valley remained the top US cluster with $210 million in first-quarter venture capital, down a little over 16 percent from the $251 million racked up a year earlier. New England's $149 million in biopharma VC marked a nearly 32 percent fall-off.

A total of six facilities comprising more than 2 million square feet are in New York's pipeline of life-sci space, according to the panelists who spoke at the New York Biotechnology Association's annual meeting this week.

Assemblymember Mark Weprin’s bill would allow New York City to award up to $250,000 in tax credits over four years to life-sci companies that build new facilities or create jobs in the Big Apple.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.